bufotenin has been researched along with pargyline in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grahame-Smith, DG; Green, AR | 1 |
| Jiang, XL; Shen, HW; Wu, C; Yu, AM | 1 |
| Geyer, MA; Halberstadt, AL; Nichols, DE | 1 |
3 other study(ies) available for bufotenin and pargyline
| Article | Year |
|---|---|
The role of brain 5-hydroxytryptamine in the hyperactivity produced in rats by lithium and monoamine oxidase inhibition.
Topics: Animals; Brain; Brain Chemistry; Bufotenin; Fenclonine; Lithium; Male; Monoamine Oxidase Inhibitors; Motor Activity; Pargyline; Rats; Serotonin; Stimulation, Chemical; Tranylcypromine; Tryptophan | 1974 |
Effects of monoamine oxidase inhibitor and cytochrome P450 2D6 status on 5-methoxy-N,N-dimethyltryptamine metabolism and pharmacokinetics.
Topics: Animals; Area Under Curve; Bufotenin; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Genotype; Half-Life; Harmaline; Hepatocytes; Humans; Isoenzymes; Kinetics; Methoxydimethyltryptamines; Methylation; Mice; Mice, Transgenic; Microsomes, Liver; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Pargyline; Phenotype; Polymorphism, Genetic; Psychotropic Drugs | 2010 |
Behavioral effects of α,α,β,β-tetradeutero-5-MeO-DMT in rats: comparison with 5-MeO-DMT administered in combination with a monoamine oxidase inhibitor.
Topics: Animals; Behavior, Animal; Bufotenin; Deuterium; Dose-Response Relationship, Drug; Drug Therapy, Combination; Male; Methoxydimethyltryptamines; Monoamine Oxidase Inhibitors; Motor Activity; Pargyline; Rats; Rats, Sprague-Dawley; Receptors, Serotonin | 2012 |